The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery
Open accessAbstract
Demyelination in MS disrupts nerve signals and contributes to axon degeneration. While remyelination promises to restore lost function, it remains unclear whether remyelination will prevent axonal loss. Inflammatory demyelination is accompanied by significant neuronal loss in the experimental autoimmune encephalomyelitis (EAE) mouse model and evidence for remyelination in this model is complicated by ongoing inflammation, degeneration and possible remyelination. Demonstrating the functional significance of remyelination necessitates selectively altering the timing of remyelination relative to inflammation and degeneration. We demonstrate accelerated remyelination after EAE induction by direct lineage analysis and hypothesize that newly formed myelin remains stable at the height of inflammation due in part to the absence of MOG expression in immature myelin. Oligodendroglial-specific genetic ablation of the M1 muscarinic receptor, a potent negative regulator of oligodendrocyte differentiation and myelination, results in accelerated remyelination, preventing axonal loss and improving functional recovery. Together our findings demonstrate that accelerated remyelination supports axonal integrity and neuronal function after inflammatory demyelination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Oligodendroglia metabolically support axons and contribute to neurodegeneration
Lee, Y., Morrison, B. M., Li, Y., Lengacher, S., Farah, M. H., Hoffman, P. N., Liu, Y., Tsingalia, A., Jin, L., Zhang, P.-W., et al. (2012) · Nature · doi:10.1038/nature11314 · Cited by 1,664
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity
Fünfschilling, U., Supplie, L. M., Mahad, D., Boretius, S., Saab, A. S., Edgar, J., Brinkmann, B. G., Kassmann, C. M., Tzvetanova, I. D., Möbius, W., et al. (2012) · Nature · doi:10.1038/nature11007 · Cited by 1,523
A Developmental Switch in the Response of DRG Neurons to ETS Transcription Factor Signaling
Hippenmeyer, S., Vrieseling, E., Sigrist, M., Portmann, T., Laengle, C., Ladle, D. R., & Arber, S. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030159 · Cited by 1,088
Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination
Lappe-Siefke, C., Goebbels, S., Gravel, M., Nicksch, E., Lee, J., Braun, P. E., Griffiths, I. R., & Nave, K.-A. (2003) · Nature Genetics · doi:10.1038/ng1095 · Cited by 1,036
Premyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis
Chang, A., Tourtellotte, W. W., Rudick, R., & Trapp, B. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa010994 · Cited by 991
Oligodendrocyte Dynamics in the Healthy Adult CNS: Evidence for Myelin Remodeling
Young, K. M., Psachoulia, K., Tripathi, R. B., Dunn, S.-J., Cossell, L., Attwell, D., Tohyama, K., & Richardson, W. D. (2013) · Neuron · doi:10.1016/j.neuron.2013.01.006 · Cited by 919 · cited 2×
“…is significantly accelerated by clemastine in the EAE model, we took advantage of a genetic approach to examine new myelin sheath generation (remyelination) by using the Cspg4-CreErt; Mapt-mGFP line in EAE (Figure 3a) (Hippenmeyer et al., 2005; Young et al., 2013; Etxeberria et al., 2016).”
BackgroundMethodAcute axonal injury in multiple sclerosis: Correlation with demyelination and inflammation
Bitsch, A. (2000) · Brain · doi:10.1093/brain/123.6.1174 · Cited by 898
Kuhlmann, T., Miron, V., Cuo, Q., Wegner, C., Antel, J., & Bruck, W. (2008) · Brain · doi:10.1093/brain/awn096 · Cited by 864
Why does remyelination fail in multiple sclerosis?
Franklin, R. J. M. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn917 · Cited by 837
Kuhlmann, T. (2002) · Brain · doi:10.1093/brain/awf235 · Cited by 775
A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis
Nikić, I., Merkler, D., Sorbara, C., Brinkoetter, M., Kreutzfeldt, M., Bareyre, F. M., Brück, W., Bishop, D., Misgeld, T., & Kerschensteiner, M. (2011) · Nature Medicine · doi:10.1038/nm.2324 · Cited by 713
Mechanisms of axon ensheathment and myelin growth
Sherman, D. L., & Brophy, P. J. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1743 · Cited by 668
Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
Trapp, B. D., & Stys, P. K. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70043-2 · Cited by 621
Mendel, I., de Rosbo, N. K., & Ben‐Nun, A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250723 · Cited by 601
Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis
Mei, F., Fancy, S. P. J., Shen, Y.-A. A., Niu, J., Zhao, C., Presley, B., Miao, E., Lee, S., Mayoral, S. R., Redmond, S. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3618 · Cited by 590
Self-citationHistamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors
Jutel, M., Watanabe, T., Klunker, S., Akdis, M., Thomet, O. A. R., Malolepszy, J., Zak-Nejmark, T., Koga, R., Kobayashi, T., Blaser, K., et al. (2001) · Nature · doi:10.1038/35096564 · Cited by 587
Bjartmar, C., Wujek, J. R., & Trapp, B. D. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00069-2 · Cited by 573
Wolswijk, G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-02-00601.1998 · Cited by 562
A regenerative approach to the treatment of multiple sclerosis
Deshmukh, V. A., Tardif, V., Lyssiotis, C. A., Green, C. C., Kerman, B., Kim, H. J., Padmanabhan, K., Swoboda, J. G., Ahmad, I., Kondo, T., et al. (2013) · Nature · doi:10.1038/nature12647 · Cited by 531
Age-dependent fate and lineage restriction of single NG2 cells
Zhu, X., Hill, R. A., Dietrich, D., Komitova, M., Suzuki, R., & Nishiyama, A. (2011) · Development · doi:10.1242/dev.047951 · Cited by 464
Axon degeneration: Molecular mechanisms of a self-destruction pathway
Wang, J. T., Medress, Z. A., & Barres, B. A. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201108111 · Cited by 442
Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo
Najm, F. J., Madhavan, M., Zaremba, A., Shick, E., Karl, R. T., Factor, D. C., Miller, T. E., Nevin, Z. S., Kantor, C., Sargent, A., et al. (2015) · Nature · doi:10.1038/nature14335 · Cited by 424
Experimental Autoimmune Encephalomyelitis in the Mouse
Miller, S. D., & Karpus, W. J. (2007) · Current Protocols in Immunology · doi:10.1002/0471142735.im1501s77 · Cited by 401
Muscarinic Acetylcholine Receptor Knockout Mice: Novel Phenotypes and Clinical Implications
Wess, J. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121622 · Cited by 380
Self-citationAnimal models of multiple sclerosis: the good, the bad and the bottom line
Ransohoff, R. M. (2012) · Nature Neuroscience · doi:10.1038/nn.3168 · Cited by 379
Axonal changes in chronic demyelinated cervical spinal cord plaques
Lovas, G., Szilagyi, N., Majtenyi, K., Palkovits, M., & Komoly, S. (2000) · Brain · doi:10.1093/brain/123.2.308 · Cited by 356
Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination
Fancy, S. P. J., Harrington, E. P., Yuen, T. J., Silbereis, J. C., Zhao, C., Baranzini, S. E., Bruce, C. C., Otero, J. J., Huang, E. J., Nusse, R., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2855 · Cited by 349 · cited 1×
“Based on our previous findings, OPC differentiation and remyelination occur between 7–14 days post lesion (dpl) (Fancy et al., 2011; Mei et al., 2014).”
MethodSelf-citationThe role of myelin and oligodendrocytes in axonal energy metabolism
Saab, A. S., Tzvetanova, I. D., & Nave, K.-A. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.09.008 · Cited by 324
Epigenome-wide differences in pathology-free regions of multiple sclerosis–affected brains
Huynh, J. L., Garg, P., Thin, T. H., Yoo, S., Dutta, R., Trapp, B. D., Haroutunian, V., Zhu, J., Donovan, M. J., Sharp, A. J., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3588 · Cited by 279
Neuroprotection and repair in multiple sclerosis
Franklin, R. J. M., ffrench-Constant, C., Edgar, J. M., & Smith, K. J. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.200 · Cited by 278
Liu, J., Dupree, J. L., Gacias, M., Frawley, R., Sikder, T., Naik, P., & Casaccia, P. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3608-15.2016 · Cited by 274
Gerber, D. J., Sotnikova, T. D., Gainetdinov, R. R., Huang, S. Y., Caron, M. G., & Tonegawa, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261583798 · Cited by 264
Oligodendroglia: metabolic supporters of axons
Morrison, B. M., Lee, Y., & Rothstein, J. D. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.07.007 · Cited by 252
Chong, S. Y. C., Rosenberg, S. S., Fancy, S. P. J., Zhao, C., Shen, Y.-A. A., Hahn, A. T., McGee, A. W., Xu, X., Zheng, B., Zhang, L. I., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113540109 · Cited by 232
Self-citationMicroglial nodules in early multiple sclerosis white matter are associated with degenerating axons
Singh, S., Metz, I., Amor, S., van der Valk, P., Stadelmann, C., & Brück, W. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1082-0 · Cited by 211
Etxeberria, A., Hokanson, K. C., Dao, D. Q., Mayoral, S. R., Mei, F., Redmond, S. A., Ullian, E. M., & Chan, J. R. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0908-16.2016 · Cited by 200
Self-citationInhibition of Gli1 mobilizes endogenous neural stem cells for remyelination
Samanta, J., Grund, E. M., Silva, H. M., Lafaille, J. J., Fishell, G., & Salzer, J. L. (2015) · Nature · doi:10.1038/nature14957 · Cited by 170
Pervasive Axonal Transport Deficits in Multiple Sclerosis Models
Sorbara, C. D., Wagner, N. E., Ladwig, A., Nikić, I., Merkler, D., Kleele, T., Marinković, P., Naumann, R., Godinho, L., Bareyre, F. M., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.11.006 · Cited by 168
Antimuscarinic Effects of Antihistamines: Quantitative Evaluation by Receptor-Binding Assay
KUBO, N., SHIRAKAWA, O., KUNO, T., & TANAKA, C. (1987) · Japanese Journal of Pharmacology · doi:10.1016/s0021-5198(19)43508-7 · Cited by 165
Axonal degeneration and progressive neurologic disability in multiple sclerosis
Bjartmar, C., & Trapp, B. D. (2003) · Neurotoxicity Research · doi:10.1007/bf03033380 · Cited by 134
Mei, F., Mayoral, S. R., Nobuta, H., Wang, F., Desponts, C., Lorrain, D. S., Xiao, L., Green, A., Rowitch, D. H., Whistler, J. L., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1493-16.2016 · Cited by 130
Self-citationAngelis, F. D., Bernardo, A., Magnaghi, V., Minghetti, L., & Tata, A. M. (2011) · Developmental Neurobiology · doi:10.1002/dneu.20976 · Cited by 127
Lee, S., Chong, S. Y. C., Tuck, S. J., Corey, J. M., & Chan, J. R. (2013) · Nature Protocols · doi:10.1038/nprot.2013.039 · Cited by 118
Self-citationFunctional Characterization of DNA Methylation in the Oligodendrocyte Lineage
Moyon, S., Huynh, J. L., Dutta, D. J., Zhang, F., Ma, D., Yoo, S., Lawrence, R., Wegner, M., John, G. R., Emery, B., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.060 · Cited by 112
Adapting brain metabolism to myelination and long‐range signal transduction
Hirrlinger, J., & Nave, K. (2014) · Glia · doi:10.1002/glia.22737 · Cited by 109
von Büdingen, H. ‐., Harrer, M. D., Kuenzle, S., Meier, M., & Goebels, N. (2008) · European Journal of Immunology · doi:10.1002/eji.200737784 · Cited by 98
Tallantyre, E. C., Bo, L., Al-Rawashdeh, O., Owens, T., Polman, C. H., Lowe, J., & Evangelou, N. (2009) · Brain · doi:10.1093/brain/awp106 · Cited by 93
A unified cell biological perspective on axon–myelin injury
Simons, M., Misgeld, T., & Kerschensteiner, M. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.201404154 · Cited by 88
Noubade, R., Milligan, G., Zachary, J. F., Blankenhorn, E. P., del Río, R., Rincón, M., & Teuscher, C. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32792 · Cited by 84
Self-citationCohen, R. I., & Almazán, G. (1994) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1994.tb00620.x · Cited by 79
Carbachol stimulates c-fos expression and proliferation in oligodendrocyte progenitors
Cohen, R. I., Molina‐Holgado, E., & Almazán, G. (1996) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00176-3 · Cited by 70
Epigenetic control of oligodendrocyte development: adding new players to old keepers
Liu, J., Moyon, S., Hernandez, M., & Casaccia, P. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2016.06.002 · Cited by 60
Presynaptic m1 muscarinic receptors are necessary for mGluR long-term depression in the hippocampus
Kamsler, A., McHugh, T. J., Gerber, D., Huang, S. Y., & Tonegawa, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912540107 · Cited by 56
Update on Disease-Modifying Treatments for Multiple Sclerosis
Carrithers, M. D. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.08.006 · Cited by 55
Ragheb, F., Molina‐Holgado, E., Cui, Q., Khorchid, A., Liu, H., Larocca, J. N., & Almazán, G. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00356.x · Cited by 54
Huang, J. K., & Franklin, R. J. M. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.01.017 · Cited by 49
Johansen, P., Weiss, A., Buenter, A., Waeckerle‐Men, Y., Fettelschoss‐Gabriel, A., Odermatt, B. F., & Kündig, T. M. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.06.023 · Cited by 28
Disease modification in multiple sclerosis: an update
Rice, C. M. (2013) · Practical Neurology · doi:10.1136/practneurol-2013-000601 · Cited by 14
Cited by
Regenerating CNS myelin — from mechanisms to experimental medicines
Franklin, R. J. M., & ffrench-Constant, C. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.136 · Cited by 647
Green, A. J., Gelfand, J. M., Cree, B. A., Bevan, C., Boscardin, W. J., Mei, F., Inman, J., Arnow, S., Devereux, M., Abounasr, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32346-2 · Cited by 593
Self-citationThe pro-remyelination properties of microglia in the central nervous system
Lloyd, A. F., & Miron, V. E. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0184-2 · Cited by 381
Preservation of a remote fear memory requires new myelin formation
Pan, S., Mayoral, S. R., Choi, H. S., Chan, J. R., & Kheirbek, M. A. (2020) · Nature Neuroscience · doi:10.1038/s41593-019-0582-1 · Cited by 365
Self-citationMyelin degeneration and diminished myelin renewal contribute to age-related deficits in memory
Wang, F., Ren, S.-Y., Chen, J.-F., Liu, K., Li, R.-X., Li, Z.-F., Hu, B., Niu, J.-Q., Xiao, L., Chan, J. R., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0588-8 · Cited by 348
Self-citation
Metadata
- Authors
- Mei, F., Lehmann-Horn, K., Shen, Y.-A. A., Rankin, K. A., Stebbins, K. J., Lorrain, D. S., Pekarek, K., A Sagan, S., Xiao, L., Teuscher, C., von Büdingen, H.-C., Wess, J., Lawrence, J. J., Green, A. J., Fancy, S. P., Zamvil, S. S., & Chan, J. R.
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2016-09-27
- Volume
- 5
- ISSN
- 2050-084X (ISSN-L)
- OpenAlex
- W2524379288
- Cited by
- 321
- References
- 60
- FWCI
- 16.42
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.